Ramanadham Jyothi Prasad

This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Natco Pharma Limited. Active years: 2011-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramanadham Jyothi Prasad. Retrieved from https://idiyas.com/inventor/ramanadham-jyothi-prasad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 75.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 9(Granted Patents)

Location History:

Hyderbad, IN (2011)
Hyderabad, IN (2012 - 2015)
Andhra Pradesh, IN (2014 - 2016)

Company Filing History:

8 out of 51

Natco Pharma Limited

patents

Years Active: 2011-2016

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9481655 - 6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors (2016-11-01),

2. 9050341 - Methods of treating drug resistant and other tumors by administering 6,7-dialkoxy quinazoline derivatives (2015-06-09),

3. 8921362 - 6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors (2014-12-30),

4. 8748602 - Polymorphs of erlotinib hydrochloride and method of preparation (2014-06-10),

5. 8664389 - Process for the preparation of lapatinib and it's pharmaceutically acceptable salts (2014-03-04),

6. 8349855 - Polymorphs of erlotinib hydrochloride and method of preparation (2013-01-08),

7. 8143250 - 6-7,dialkoxy quinazoline derivatives useful for treatment of cancer related disorders (2012-03-27),

8. 7960545 - Process for the prepartion of erlotinib (2011-06-14),

Title: Innovator Spotlight: Ramanadham Jyothi Prasad

Introduction: Ramanadham Jyothi Prasad is a distinguished inventor based in Hyderabad, Telangana, India. With an impressive portfolio of 8 patents, he has made significant contributions to the field of pharmaceutical innovation, particularly in areas targeting cancer treatment.

Latest Patents: Prasad's latest patents showcase his groundbreaking work on 6,7-dialkoxy quinazoline derivatives. These patents include methods aimed at treating drug-resistant tumors and various specific cancers, such as pancreatic cancer and HER2-positive breast cancer. His innovative approaches employ compounds of formula (I) to inhibit the growth of tumor cells, providing hope for subjects in need of effective treatments. The detailed methods involve administering pharmaceutically acceptable salts of these compounds, highlighting his commitment to developing practical therapeutic applications.

Career Highlights: Currently, Prasad is associated with Natco Pharma Limited, where he engages in research and development initiatives aimed at creating life-saving medications. His deep understanding of medicinal chemistry and tumor biology has led to advancements that may improve patient outcomes in oncology.

Collaborations: In his journey, Prasad has collaborated with several notable colleagues, including Nannapaneni Venkaiah Chowdary and Bhujanga Rao Adibhatla Kali Satya. Together, they have fostered an environment of innovation that drives their collective success in the pharmaceutical industry.

Conclusion: Ramanadham Jyothi Prasad is a visionary inventor whose work continues to shape the landscape of cancer treatment. Through his patents and collaborations, he embodies the spirit of innovation and dedication to public health, making a lasting impact on medical research and patient care.

Profile summary based on public USPTO records.